Skip to main content

Recent News

In our September issue—Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection https://t.co/IqHp2GMLao https://t.co/Prvw8OBTvH
The Lancet Rheumatology @TheLancetRheum (  View Tweet)
Sep 19, 2020
Lisa Sammaritano, MD, stresses that there must be communication between rheumatologists and OB-GYNs when it comes to addressing pregnancy for #rheumatology patients. #CCREast https://t.co/j1IH6gsKnk

HCPLive @MDMagazine (  View Tweet)

Sep 19, 2020
Thank you all who participated in the survey. Here are some of our results #Covid_19 #rheumatology https://t.co/55ETf6kK6T

Bella Mehta @bella_mehta (  View Tweet)

Sep 19, 2020
Dr. S. Louis “Lou” Bridges, Jr. (@HSS_PIC) shares what led him to HSS and what he hopes to do as the Chief of the Division of Rheumatology. For more about Dr. Bridges visit https://t.co/oNiQxlLFeP. https://t.co/2vcLwUZJYQ
Hosp Special Surgery @HSpecialSurgery (  View Tweet)
Sep 19, 2020
"It’s a very difficult transition for providers to care for patients without a physical exam." #rheumatology #telemedicine @DartmouthHitch https://t.co/ZSHmVqXDaT

HCPLive @MDMagazine (  View Tweet)

Sep 19, 2020
The RheumNow podcast is up! Lupus delights - Lupus & Diet, Drug induced lupus & brand new biologics for SLE. Good news on immunosuppressives, colchicine and baricitinib in COVID-19 patients. .

Dr. John Cush @RheumNow (  View Tweet)

Sep 18, 2020
Lupus Delights https://t.co/20FOr3qu3X https://t.co/AdRoaLDAmt
Dr. John Cush @RheumNow (  View Tweet)
Sep 18, 2020

COVID-19 Risks in Pregnant Women

Sep 17, 2020

There has been little science or evidence regarding the effects of COVID-19 infection on pregnancy and vice versa; and now the recent MMWR addresses the subject with two new reports

Read Article

Methotrexate-Pegloticase Combination in Refractory Gout - MIRROR Study

Sep 17, 2020

The MIRROR study, an open-label pilot trial in refractory, uncontrolled gout patients, showed that pegloticase given in combination with methotrexate was safe and effective and maintained responses for 6 months after initiation. 

Read Article
Doximity's 2020 State of Telemedicine report shows the top 10 specialties using telemedicine: 1. Endocrinology; 2. Rheumatology; 3. Gastroenterology, followed by Nephrology Cardiology GU Neurology Geriatrics Heme/onc Pulmonology https://t.co/J4Dt24ZlYg

Dr. John Cush @RheumNow (  View Tweet)

Sep 17, 2020
Nurses' Health Study (79,568 women) examined the role of diet in 194 incident SLE cases and showed that diets (DASH, Meditteranean, antiinflammatory & healthy diets) had no significant effect of dietary quality on SLE risk https://t.co/JAFirjt0O8

Dr. John Cush @RheumNow (  View Tweet)

Sep 17, 2020
NEJM report of 2 SLE pts treated w/ Daratumumab (anti-CD38) to deplete plasma cells a life-threatening refractory SLE.

Dr. John Cush @RheumNow (  View Tweet)

Sep 17, 2020

Belimumab Effective in Lupus Nephritis

Sep 16, 2020

Dr. Rich Furie has lead a group of investIgators in reporting the significant efficacy of intravenous belimumab when added to standard of care induction therapy in patients with active lupus nephritis. This phase 3, 2-year study included 448 systemic lupus erythematosus patients with biopsy proven lupus nephritis (class III or IV +/- V) patients who required induction therapy and have a UPCR ≥1 g/g. 

Read Article

Has the Risk of Hip Fracture Changed over Time?

Sep 16, 2020

Data from the Framingham Heart Study has shown that hip fracture incidence has decreased over time, probably resulting from improved lifestyle changes (less smoking and heavy drinking). 

The incidence of hip fracture has been shown to be decreasing in the US, presumeably attributeable to better osteoporosis treatment and care. This study examined the hip fracture incidence over the past 40 years in the US.

Read Article

NSAIDs Shows No Advantage over CBT in Knee Osteoarthritis

Sep 16, 2020

JAMA Internal Medicine reports on a controlled clinical trial of knee osteoarthritis patients wherein meloxicam responses were not significantly or clinically superior to placebo or CBT (after placebo).

Because of the uncertain benefits and safety of long-term NSAIDs, investigators sought to evaluate the comparative efficacy and safety of cognitive behavioral therapy (CBT) in knee osteoarthritis.

Read Article
COPDGene study of 361 DISH pts shows DISH carrieds a higher risk of coronary artery disease (OR 1.37 [1.05-1.78] (p=0.019), as measured by coronary calcium scores: 8.8% had CAC = 0; 12.8% CAC1-100; 20.0% CAC100-400 and 24.7% had a CAC>400.

Dr. John Cush @RheumNow (  View Tweet)

Sep 16, 2020
Retrospective cohort study of 213 IMID patients, 36.2% tested positive for COVID-19, who had no greater risk of hospitalized or ventilation and immunosuppressive use was not shown to worsened the course of disease (TNFi decreased risk of hospitalization) https://t.c

Dr. John Cush @RheumNow (  View Tweet)

Sep 16, 2020
Taiwan National Health population study of 650 SLE and non-SLE controls undergoing hip replacement. SLE did not incr risk of early prosthetic infx, but did incr risk of late superficial wound infection (11.4% vs.

Dr. John Cush @RheumNow (  View Tweet)

Sep 16, 2020
Uncontrolled retrospective observational study of 31 RA-ILD DMARD refractory pts treated with RTX showed RTX to reverse the PFTs decline (∆%pFVC +8.06%; ∆%pDLCO +12.7%) while reducing median prednisone dose at 1 yr. @32 mos, 74% still on RTX.

Dr. John Cush @RheumNow (  View Tweet)

Sep 16, 2020
Baricitinib in combo with Remdesivir reduces time to recovery in COVID-19 hospitalized pts in NIH-run ACTT-2 Trial w/ >1000 pts randomized to recv 4-mg baricitinib plus remdesivir versus remdesivir alone.

Dr. John Cush @RheumNow (  View Tweet)

Sep 16, 2020
×